Myocor (Acquired)

Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Myocor (Acquired) plus 5456 other startups.